Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks for that response. Nice to have an expert on this situation here. They clearly did this for a reason and my current guess is that they needed control to achieve a goal that involves multiple companies within the family. They seem to have control of the related entities which remain current.
Now that the company is a private entity they can essentially do whatever they want, including any corporate actions without any shareholder input or vote. It boils down to the ethics of the company.
If management didn't have the controlling vote like they do in their other tickers I wonder if the revocation allows them to take action without a share holder vote?
That's a good sign that the company is still registered in a U.S. State. Now all they have to do is file a FORM 10 to reregister with the SEC.
Best o' luck!!!!!!!!!!!!!!!!!
Thanks. I had thought that page was dead with the revocation. I'll watch it. I noticed that the PA Secretary of State shows it as a foreign corporation incorporated in DE. It did not have the trailing F in the ticker. I didn't get any results in DE but PA shows it still registered.
You will find everything you need under this EDGAR link:
https://www.sec.gov/cgi-bin/browse-edgar?company=Neuropathix+&match=starts-with&filenum=&State=&Country=&SIC=&myowner=exclude&action=getcompany
As I research the Form10 process it occurs to me that you may have some of the answers that I seek. Can you advise if the Form 10 application is searchable? Is there a list of new Form 10's on line? I don't want to miss it if they change the name and file under a different name. How would you proceed if you desired to monitor this situation?
Thank you for sharing that. It seems to me that this was an intentional move to achieve some objective that I expect to be revealed by year end. It did not just happen by mistake. Meanwhile the company is moving ahead like nothing went wrong so I think that the company is on track to its plan.
You are correct that shareholders retain the exact number of shares held before revocation, but the shares cannot trade on any public market.
FWIW and FYI, to reregister the company must file a FORM 10 that has at least 2 years of audited Financials. The SEC uses a hubble-sized microscope to examine any FORM 10's so the company must be 100% accurate and complete in any/all disclosures.
Best of luck, Blue Skys and all other shareholders.
It is clear that the company desired to be revoked. The reasons that I can conceive today are:
1. They did something that they do not desire to disclose and intend to relist and continue.
2. They don't have sufficient shares controlled by insiders and they desire to participate in a transaction that would require shareholder approval such as M&A or an equity transaction.
My understanding is that investors retain their ownership share but may only trade it off market until relisting if that happens.
It is interesting that this has occurred simultaneously with the delay of the AXIM OS increase by not sending the shareholder letter on or about August 29th and Versea's apparent desire to become publicly listed as well as NPTX's parent company MJNA being in need of capital.
Something looks to be happening that is complicated and involves multiple enterprises run by the family.
NPTX: SEC registration revoked:
https://www.sec.gov/files/litigation/admin/2023/34-98774.pdf
By accepting the revocation the company can now file a new FORM 10 to reregister.
Excerpt:
Solely for the purpose of these proceedings and any other proceedings brought by or on
behalf of the Commission, or to which the Commission is a party, and without admitting or
denying the findings herein, except as to the Commission’s jurisdiction over it and the subject
matter of these proceedings, which are admitted, Respondent consents to the entry of this Order
Making Findings and Revoking Registration of Securities Pursuant to Section 12(j) of the
Securities Exchange Act of 1934 as to Neuropathix, Inc. (“Order”), as set forth below.
I wonder when Dean is going to wake up and catch up on his filings? AXIM filed to increase the OS, MJNA is just about out of shares, Versea needs a ticker and NPTX is on the verge of having their ticker yanked by the SEC. The family is up to something that's for sure. They always do things differently from other companies. This gag is interesting.
I hope the show went well for Neuropathix this week in NYC. Someone had the nerve to post the SEC Administrative action above their show announcement on Linked In.
https://www.linkedin.com/search/results/all/?fetchDeterministicClustersOnly=true&heroEntityKey=urn%3Ali%3Aorganization%3A69506797&keywords=neuropathix%2C%20inc.&origin=RICH_QUERY_TYPEAHEAD_HISTORY&position=0&searchId=2fd76d37-d1c7-4bf9-a776-983d07f7ea1e&sid=UNU&spellCorrectionEnabled=true
If Neuropathix Inc is serious about remaining a public company their best , quickest and only option is to respectfully accept revocation and then file a new FORM 10 to reregister. The SEC likes companies that accept responsibility for delinquent Financials and they are more prone to approving a new FORM 10. Conversely, if a company doesn't accept responsibility and the Admin. Law Judges have to forcefully revoke that company's registration it is far more unlikely the SEC would approve a new FORM 10 and Neuropathix Inc would remain a private company after their SEC registration is revoked.
That assessment is derived from studying over 2,300 public companies since 2010 that were severely delinquent in filing their Financials.
Dr. Dean and Crew are still alive and kicking with a conference coming up in 2 days!
Please join Neuropathix, Inc. subsidiary Kannalife Sciences, Inc. on October 11, 2023 at the NIH Life Sciences Summit at the Alexandria Life Sciences Center in NYC
We're proud to be only one of fifteen innovative, fundable, early-stage life sciences companies selected by NIH to present our breakthrough technology to treat neuropathic pain, inflammation and addiction.
#Kannalife #Neuropathix #LifeSciSummit #Biotech #Innovation #InvestmentOpportunity #NYC #EmergingCompanies #EarlyStageInvesting #ScienceLeadership #NIHSummit2023 #HealthcareInnovation #PitchDoctors #StrategicPartners #InvestorsUnite
https://lnkd.in/djp--HfM
Thanks for your response! It is very interesting because with the connections and cross ownership that this company enjoys whatever is happening with this company must be intentional. There are a lot of changes in progress at two and maybe 3 of the sister companies. Would it be accurate that the company could catch up on its filings any time before the Administrative Judges decision and abort the process? Since you have watched many of these how long would you think it could take from the letter received 14 days ago to revocation of the ticker in the event that NPTX elects not to respond? I believe that in the event of revocation company ownership is essentially frozen and retained by the existing investors. In that case I suspect that the officers could make business decisions that would normally require a shareholder vote. I am searching for the reason that this situation has been created and what the path forward for these companies all controlled by the same "family" of characters.
You have the correct link to follow the developments of the SEC's O.I.P.
From 2010 in all instances that I have followed Admin Proceedings for severely delinquent Financials the Admin. Law Judges have revoked the registrations of all of them, notwithstanding a few stocks where the O.I.P.'s were withdrawn a few months ago because Enforcement made errors. Enforcement isn't likely to make other errors going forward.
Renee here is my search result. If there is something that I should have done differently please post it. You have a lot more experience with enforcement than I do.
https://www.sec.gov/litigation/apdocuments/3-21716
14 days have passed since the demand letter for the company to respond to the administrative action within 10 days with no response from NPTX. It would seem that if the company desired to maintain its listing it would have responded. The pre hearing conference is to be scheduled after the company response so no hearing has been scheduled. It seems to me that NPTX is about to receive a letter with a decision that they are in default and the ticker suspended or revoked. I'm surprised that the note holders are not beating down Dean's door demanding that he file. It sure looks like it is intentional and part of some sort of reorganization.
What do you think Renee? You have been following NPTX more closely than I have. Right now I'm glad that I didn't buy that much of it but yet confident that MJNA and the note holders will insure that investors are protected.
That's some good search info. I was aware that they were delinquent but thought that I was following by watching Edgar. There are a few other stocks that I can apply that to.
SEC Admin. Proceedings are not required filings on EDGAR. However, by accessing Neuropathix's EDGAR filings readers would have been able to see that the company was delinquent in filing their Financials and that the SEC could, and in this case would file an SEC Enforcement Admin. Proceeding for the delinquent Financials.
In all cases SEC Admin. Proceedings are after-the-fact proceedings for Securities violations:
https://www.sec.gov/litigation/admin
General link to SEC Enforcement:
https://www.sec.gov/page/litigation
Neuropathix SEC EDGAR link:
https://www.sec.gov/cgi-bin/browse-edgar?company=neuropathix&match=starts-with&filenum=&State=&Country=&SIC=&myowner=exclude&action=getcompany
I'm curious how you found that. I don't see it on Edgar or OTC Markets, but there it is.
NPTX: SEC Admin. Proceeding for severely delinquent Financials:
https://www.sec.gov/files/litigation/admin/2023/34-98507_0.pdf
Together, these data suggest that KLS-13019 represents a new class of drug that would be potentially useful for the treatment of neuropathic pain, and these animal models in combination with molecular techniques will describe the role of GPR55 in neuropathic pain to provide the proof-of-concept for a novel therapeutic strategy for this affliction.
https://jpet.aspetjournals.org/content/385/S3/66
Maybe we'll get an update when MJNA files their Quarterly report. All these little otc companies are trying to time the wave that's coming some day IMHO
Interesting that they filed their OTCQB certification while being diluent and on the Expert Market. Maybe there is a sign of life.
What happened to this stock. The grant was such good news for a promising new drug. I can't find anything to explain the drop in share price. Can anyone shed light on this for me?
Big volume day!
Of course I'll post it. Right after I get done with any trading that I might feel the impulse to execute.
If someone learns that trading has resumed, could someone please post this?
Feels like about 4 - 6 months back. People were PM ing her and she was sending details. I think quite a few lawyers in the great white north are doing this. Personally I don't believe that The Whale is biologically female but it's a good gag.
Look for the post under GVSI but unable to find. Any idea how long ago the post was made on how to buy?
There are lawyers in Canada who are doing this as a service to US clients. The Whale coached a number of investors on how to purchase GVSI some time back on that board.
I wanted to pick up few shares but not possible using Schwab or Ameritrade. Need to wait until the company is up to date on filings? Any ideas?
Hopefully this thing comes back to life. They need to hook a big funding fish with KLS13019.
That's interesting. Maybe there is a future here.
I couldn't resist getting a little NPTX here. Delinquent filer, out of cash, CEO selling. This is my kind of stock!
never hurts to ask !!!!! 'Neuropathix Inc. (NPTX)'
anything else my friend
good to hear from you
looking for a risky play in mj sector
liking the chatter lately
cannabis is behind times as product to u.s.a. when approved by gov't runs fast.
n.f.l. is weighing use for football players---02-01-2022
re;
Neuropathix Inc (QB) (NPTX)
0.0364 ? 0.0004 (1.11%)
Volume: 259,866 @02/02/22 3:13:29 PM EST
Bid Ask Day's Range
0.03 0.0724 0.03 - 0.0364
NPTX Detailed Quote